Report cover image

Global Solid Tumors Target Proteins Industry Growth and Trends Forecast to 2031

Publisher APO Research, Inc.
Published Jul 07, 2025
Length 101 Pages
SKU # APRC20339092

Description

Summary

According to APO Research, The global Solid Tumors Target Proteins market was estimated at US$ million in 2025 and is projected to reach a revised size of US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2026-2031.

North American market for Solid Tumors Target Proteins is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for Solid Tumors Target Proteins is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Europe market for Solid Tumors Target Proteins is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

The major global companies of Solid Tumors Target Proteins include Novartis, Sino Biological, ACRO Biosystems, TargetMol Chemicals, ProteoGenix, Kite Pharma, Kactus Biosystems, Juno Therapeutics and Elabscience, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Solid Tumors Target Proteins, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Solid Tumors Target Proteins.

The Solid Tumors Target Proteins market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Solid Tumors Target Proteins market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

Solid Tumors Target Proteins Segment by Company

Novartis
Sino Biological
ACRO Biosystems
TargetMol Chemicals
ProteoGenix
Kite Pharma
Kactus Biosystems
Juno Therapeutics
Elabscience
Creative BioMart
Creative Biolabs
Bio-Techne
Bio X Cell
ACROBiosystems
Solid Tumors Target Proteins Segment by Type

EGFR Protein
HER2 Protein
Others
Solid Tumors Target Proteins Segment by Application

Hospital
Biological Laboratory
Others
Solid Tumors Target Proteins Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Solid Tumors Target Proteins market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Solid Tumors Target Proteins and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Solid Tumors Target Proteins.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2020-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Solid Tumors Target Proteins companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

101 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Solid Tumors Target Proteins Market Size Overview by Region 2020 VS 2024 VS 2031
1.4 Global Solid Tumors Target Proteins Market Size by Region (2020-2031)
1.4.1 Global Solid Tumors Target Proteins Market Size by Region (2020-2025)
1.4.2 Global Solid Tumors Target Proteins Market Size by Region (2026-2031)
1.5 Key Regions Solid Tumors Target Proteins Market Size (2020-2031)
1.5.1 North America Solid Tumors Target Proteins Market Size Growth Rate (2020-2031)
1.5.2 Europe Solid Tumors Target Proteins Market Size Growth Rate (2020-2031)
1.5.3 Asia-Pacific Solid Tumors Target Proteins Market Size Growth Rate (2020-2031)
1.5.4 South America Solid Tumors Target Proteins Market Size Growth Rate (2020-2031)
1.5.5 Middle East & Africa Solid Tumors Target Proteins Market Size Growth Rate (2020-2031)
2 Solid Tumors Target Proteins Market by Type
2.1 Type Introduction
2.1.1 EGFR Protein
2.1.2 HER2 Protein
2.1.3 Others
2.2 Global Solid Tumors Target Proteins Market Size by Type
2.2.1 Global Solid Tumors Target Proteins Market Size Overview by Type (2020-2031)
2.2.2 Global Solid Tumors Target Proteins Historic Market Size Review by Type (2020-2025)
2.2.3 Global Solid Tumors Target Proteins Market Size Forecasted by Type (2026-2031)
2.3 Global Solid Tumors Target Proteins Market Size by Regions
2.3.1 North America Solid Tumors Target Proteins Market Size Breakdown by Type (2020-2025)
2.3.2 Europe Solid Tumors Target Proteins Market Size Breakdown by Type (2020-2025)
2.3.3 Asia-Pacific Solid Tumors Target Proteins Market Size Breakdown by Type (2020-2025)
2.3.4 South America Solid Tumors Target Proteins Market Size Breakdown by Type (2020-2025)
2.3.5 Middle East and Africa Solid Tumors Target Proteins Market Size Breakdown by Type (2020-2025)
3 Solid Tumors Target Proteins Market by Application
3.1 Type Introduction
3.1.1 Hospital
3.1.2 Biological Laboratory
3.1.3 Others
3.2 Global Solid Tumors Target Proteins Market Size by Application
3.2.1 Global Solid Tumors Target Proteins Market Size Overview by Application (2020-2031)
3.2.2 Global Solid Tumors Target Proteins Historic Market Size Review by Application (2020-2025)
3.2.3 Global Solid Tumors Target Proteins Market Size Forecasted by Application (2026-2031)
3.3 Global Solid Tumors Target Proteins Market Size by Regions
3.3.1 North America Solid Tumors Target Proteins Market Size Breakdown by Application (2020-2025)
3.3.2 Europe Solid Tumors Target Proteins Market Size Breakdown by Application (2020-2025)
3.3.3 Asia-Pacific Solid Tumors Target Proteins Market Size Breakdown by Application (2020-2025)
3.3.4 South America Solid Tumors Target Proteins Market Size Breakdown by Application (2020-2025)
3.3.5 Middle East and Africa Solid Tumors Target Proteins Market Size Breakdown by Application (2020-2025)
4 Global Market Dynamics
4.1 Solid Tumors Target Proteins Industry Trends
4.2 Solid Tumors Target Proteins Industry Drivers
4.3 Solid Tumors Target Proteins Industry Opportunities and Challenges
4.4 Solid Tumors Target Proteins Industry Restraints
5 Competitive Insights by Company
5.1 Global Top Players by Solid Tumors Target Proteins Revenue (2020-2025)
5.2 Global Solid Tumors Target Proteins Industry Company Ranking, 2023 VS 2024 VS 2025
5.3 Global Solid Tumors Target Proteins Key Company Headquarters & Area Served
5.4 Global Solid Tumors Target Proteins Company, Product Type & Application
5.5 Global Solid Tumors Target Proteins Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Solid Tumors Target Proteins Market CR5 and HHI
5.6.2 Global Top 5 and 10 Solid Tumors Target Proteins Players Market Share by Revenue in 2024
5.6.3 2024 Solid Tumors Target Proteins Tier 1, Tier 2, and Tier 3
6 Company Profiles
6.1 Novartis
6.1.1 Novartis Comapny Information
6.1.2 Novartis Business Overview
6.1.3 Novartis Solid Tumors Target Proteins Revenue, Global Share and Gross Margin (2020-2025)
6.1.4 Novartis Solid Tumors Target Proteins Product Portfolio
6.1.5 Novartis Recent Developments
6.2 Sino Biological
6.2.1 Sino Biological Comapny Information
6.2.2 Sino Biological Business Overview
6.2.3 Sino Biological Solid Tumors Target Proteins Revenue, Global Share and Gross Margin (2020-2025)
6.2.4 Sino Biological Solid Tumors Target Proteins Product Portfolio
6.2.5 Sino Biological Recent Developments
6.3 ACRO Biosystems
6.3.1 ACRO Biosystems Comapny Information
6.3.2 ACRO Biosystems Business Overview
6.3.3 ACRO Biosystems Solid Tumors Target Proteins Revenue, Global Share and Gross Margin (2020-2025)
6.3.4 ACRO Biosystems Solid Tumors Target Proteins Product Portfolio
6.3.5 ACRO Biosystems Recent Developments
6.4 TargetMol Chemicals
6.4.1 TargetMol Chemicals Comapny Information
6.4.2 TargetMol Chemicals Business Overview
6.4.3 TargetMol Chemicals Solid Tumors Target Proteins Revenue, Global Share and Gross Margin (2020-2025)
6.4.4 TargetMol Chemicals Solid Tumors Target Proteins Product Portfolio
6.4.5 TargetMol Chemicals Recent Developments
6.5 ProteoGenix
6.5.1 ProteoGenix Comapny Information
6.5.2 ProteoGenix Business Overview
6.5.3 ProteoGenix Solid Tumors Target Proteins Revenue, Global Share and Gross Margin (2020-2025)
6.5.4 ProteoGenix Solid Tumors Target Proteins Product Portfolio
6.5.5 ProteoGenix Recent Developments
6.6 Kite Pharma
6.6.1 Kite Pharma Comapny Information
6.6.2 Kite Pharma Business Overview
6.6.3 Kite Pharma Solid Tumors Target Proteins Revenue, Global Share and Gross Margin (2020-2025)
6.6.4 Kite Pharma Solid Tumors Target Proteins Product Portfolio
6.6.5 Kite Pharma Recent Developments
6.7 Kactus Biosystems
6.7.1 Kactus Biosystems Comapny Information
6.7.2 Kactus Biosystems Business Overview
6.7.3 Kactus Biosystems Solid Tumors Target Proteins Revenue, Global Share and Gross Margin (2020-2025)
6.7.4 Kactus Biosystems Solid Tumors Target Proteins Product Portfolio
6.7.5 Kactus Biosystems Recent Developments
6.8 Juno Therapeutics
6.8.1 Juno Therapeutics Comapny Information
6.8.2 Juno Therapeutics Business Overview
6.8.3 Juno Therapeutics Solid Tumors Target Proteins Revenue, Global Share and Gross Margin (2020-2025)
6.8.4 Juno Therapeutics Solid Tumors Target Proteins Product Portfolio
6.8.5 Juno Therapeutics Recent Developments
6.9 Elabscience
6.9.1 Elabscience Comapny Information
6.9.2 Elabscience Business Overview
6.9.3 Elabscience Solid Tumors Target Proteins Revenue, Global Share and Gross Margin (2020-2025)
6.9.4 Elabscience Solid Tumors Target Proteins Product Portfolio
6.9.5 Elabscience Recent Developments
6.10 Creative BioMart
6.10.1 Creative BioMart Comapny Information
6.10.2 Creative BioMart Business Overview
6.10.3 Creative BioMart Solid Tumors Target Proteins Revenue, Global Share and Gross Margin (2020-2025)
6.10.4 Creative BioMart Solid Tumors Target Proteins Product Portfolio
6.10.5 Creative BioMart Recent Developments
6.11 Creative Biolabs
6.11.1 Creative Biolabs Comapny Information
6.11.2 Creative Biolabs Business Overview
6.11.3 Creative Biolabs Solid Tumors Target Proteins Revenue, Global Share and Gross Margin (2020-2025)
6.11.4 Creative Biolabs Solid Tumors Target Proteins Product Portfolio
6.11.5 Creative Biolabs Recent Developments
6.12 Bio-Techne
6.12.1 Bio-Techne Comapny Information
6.12.2 Bio-Techne Business Overview
6.12.3 Bio-Techne Solid Tumors Target Proteins Revenue, Global Share and Gross Margin (2020-2025)
6.12.4 Bio-Techne Solid Tumors Target Proteins Product Portfolio
6.12.5 Bio-Techne Recent Developments
6.13 Bio X Cell
6.13.1 Bio X Cell Comapny Information
6.13.2 Bio X Cell Business Overview
6.13.3 Bio X Cell Solid Tumors Target Proteins Revenue, Global Share and Gross Margin (2020-2025)
6.13.4 Bio X Cell Solid Tumors Target Proteins Product Portfolio
6.13.5 Bio X Cell Recent Developments
6.14 ACROBiosystems
6.14.1 ACROBiosystems Comapny Information
6.14.2 ACROBiosystems Business Overview
6.14.3 ACROBiosystems Solid Tumors Target Proteins Revenue, Global Share and Gross Margin (2020-2025)
6.14.4 ACROBiosystems Solid Tumors Target Proteins Product Portfolio
6.14.5 ACROBiosystems Recent Developments
7 North America
7.1 North America Solid Tumors Target Proteins Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
7.2 North America Solid Tumors Target Proteins Market Size by Country (2020-2025)
7.3 North America Solid Tumors Target Proteins Market Size Forecast by Country (2026-2031)
8 Europe
8.1 Europe Solid Tumors Target Proteins Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
8.2 Europe Solid Tumors Target Proteins Market Size by Country (2020-2025)
8.3 Europe Solid Tumors Target Proteins Market Size Forecast by Country (2026-2031)
9 Asia-Pacific
9.1 Asia-Pacific Solid Tumors Target Proteins Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
9.2 Asia-Pacific Solid Tumors Target Proteins Market Size by Country (2020-2025)
9.3 Asia-Pacific Solid Tumors Target Proteins Market Size Forecast by Country (2026-2031)
10 South America
10.1 South America Solid Tumors Target Proteins Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
10.2 South America Solid Tumors Target Proteins Market Size by Country (2020-2025)
10.3 South America Solid Tumors Target Proteins Market Size Forecast by Country (2026-2031)
11 Middle East & Africa
11.1 Middle East & Africa Solid Tumors Target Proteins Market Size Growth Rate (CAGR) by Country: 2020 VS 2024 VS 2031
11.2 Middle East & Africa Solid Tumors Target Proteins Market Size by Country (2020-2025)
11.3 Middle East & Africa Solid Tumors Target Proteins Market Size Forecast by Country (2026-2031)
12 Concluding Insights
13 Appendix
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.